Role of complement system in patients with biopsy-proven immunoglobulin G4-related kidney disease

Hum Pathol. 2018 Nov:81:220-228. doi: 10.1016/j.humpath.2018.07.008. Epub 2018 Jul 18.

Abstract

Hypocomplementemia has been frequently reported in immunoglobulin G4-related kidney disease (IgG4-RKD). However, studies on the role of complement system in IgG4-RKD are lacking. A total of 40 429 renal biopsies from January 2010 to January 2018 were reexamined in the present study, and 17 patients were confirmed to meet the criteria of IgG4-RKD. According to the serum C3 levels, they were divided into 2 groups: the low-C3 group (C3 <0.8 g/L, n = 7) and the normal-C3 group (C3 ≥0.8 g/L, n = 10). Compared with the normal-C3-level group, the patients in the low-C3-level group had lower serum C4 concentrations (P = .025), higher serum IgG4 concentrations (P = .003), higher positive rates in rheumatoid factor (P = .033), more severe storiform fibrosis (P = .007) at diagnosis, and higher blood urea nitrogen levels at the latest test (P = .04). The serum levels of C3 were in negative correlation with the serum levels of IgG4 (P = .003), the levels of rheumatoid factor (P = .002), renal deposition of C1q (P = .028), storiform fibrosis (P < .001), scores of interstitial fibrosis (P = .015), the amount of renal IgG4-positive (IgG4+) plasma cells (P = .020), the ratios of IgG4+ plasma cells/CD138+ cells (P = .018), and the blood urea nitrogen concentrations at the last test (P = .023). Our study shows that IgG4-RKD is a relatively rare entity. Complement system may participate in the development of IgG4-RKD.

Keywords: Complement; IgG4-related kidney disease; Membranous glomerulonephritis; Storiform fibrosis; Tubulointerstitial nephritis.

MeSH terms

  • Adult
  • Aged
  • Biopsy
  • Complement Activation* / drug effects
  • Complement C1q / immunology
  • Complement C3 / immunology
  • Complement C4 / immunology
  • Complement System Proteins / immunology*
  • Female
  • Fibrosis
  • Glomerulonephritis, Membranous / blood
  • Glomerulonephritis, Membranous / diagnosis
  • Glomerulonephritis, Membranous / drug therapy
  • Glomerulonephritis, Membranous / immunology*
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology*
  • Immunoglobulin G4-Related Disease / blood
  • Immunoglobulin G4-Related Disease / diagnosis
  • Immunoglobulin G4-Related Disease / drug therapy
  • Immunoglobulin G4-Related Disease / immunology*
  • Immunosuppressive Agents / therapeutic use
  • Kidney / drug effects
  • Kidney / immunology*
  • Kidney / pathology
  • Male
  • Middle Aged
  • Nephritis, Interstitial / blood
  • Nephritis, Interstitial / diagnosis
  • Nephritis, Interstitial / drug therapy
  • Nephritis, Interstitial / immunology*
  • Plasma Cells / drug effects
  • Plasma Cells / immunology*
  • Plasma Cells / pathology
  • Retrospective Studies
  • Rheumatoid Factor / blood
  • Rheumatoid Factor / immunology
  • Risk Factors
  • Treatment Outcome

Substances

  • C3 protein, human
  • Complement C3
  • Complement C4
  • Glucocorticoids
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Complement C1q
  • Complement System Proteins
  • Rheumatoid Factor